These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11127396)

  • 1. Leucovorin and maximum tolerated dose toxicity of methotrexate in rats.
    Fuskevåg OM; Kristiansen C; Lindal S; Aarbakke J
    Pediatr Hematol Oncol; 2000 Dec; 17(8):651-8. PubMed ID: 11127396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximum tolerated doses of methotrexate and 7-hydroxy-methotrexate in a model of acute toxicity in rats.
    Fuskevåg OM; Kristiansen C; Lindal S; Aarbakke J
    Cancer Chemother Pharmacol; 2000; 46(1):69-73. PubMed ID: 10912581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose leucovorin reverses acute high-dose methotrexate neurotoxicity in the rat.
    Phillips PC; Thaler HT; Allen JC; Rottenberg DA
    Ann Neurol; 1989 Apr; 25(4):365-72. PubMed ID: 2785366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P; Oviedo I; Campbell M; Tordecilla J
    Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in dose intensity of high-dose methotrexate for nonmetastatic osteosarcoma.
    Leavey PJ; Mantadakis E; Maale G
    Pediatr Hematol Oncol; 2002; 19(7):483-9. PubMed ID: 12217194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy.
    Schwartz S; Borner K; Müller K; Martus P; Fischer L; Korfel A; Auton T; Thiel E
    Oncologist; 2007 Nov; 12(11):1299-308. PubMed ID: 18055849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Toxicosis of high-dose methotrexate (HD-MTX) for osteosarcoma, cured with treatment by leucovorin (LV) rescue and hemoperfusion--a case report].
    Kobayashi H; Morita T; Hirata Y; Kato T; Okada Y; Sato T
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):475-8. PubMed ID: 10740644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia.
    Skärby TV; Anderson H; Heldrup J; Kanerva JA; Seidel H; Schmiegelow K;
    Leukemia; 2006 Nov; 20(11):1955-62. PubMed ID: 16990760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration by leucovorin of methotrexate developmental toxicity in rabbits.
    DeSesso JM; Goeringer GC
    Teratology; 1991 Mar; 43(3):201-15. PubMed ID: 2014483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of the 48-hour plasma level in high-dose methotrexate regimens.
    Perez C; Wang YM; Sutow WW; Herson J
    Cancer Clin Trials; 1978; 1(2):107-11. PubMed ID: 316368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taurine protects against methotrexate-induced toxicity and inhibits leukocyte death.
    Cetiner M; Sener G; Sehirli AO; Ekşioğlu-Demiralp E; Ercan F; Sirvanci S; Gedik N; Akpulat S; Tecimer T; Yeğen BC
    Toxicol Appl Pharmacol; 2005 Nov; 209(1):39-50. PubMed ID: 15890378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leucovorin rescue from raltitrexed (tomudex)-induced antiproliferative effects: in vitro cell line and in vivo mouse studies.
    Farrugia DC; Aherne GW; Brunton L; Clarke SJ; Jackman AL
    Clin Cancer Res; 2000 Sep; 6(9):3646-56. PubMed ID: 10999757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
    Zelcer S; Kellick M; Wexler LH; Gorlick R; Meyers PA
    Pediatr Blood Cancer; 2008 Jun; 50(6):1176-80. PubMed ID: 18266225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential laboratory determinations for monitoring high-dose methotrexate treatment with citrovorum factor rescue.
    Jürgens H; Ebell W; Bachmann R; Kupke I; Richter O; Andräs A; Göbel U
    Pediatr Pharmacol (New York); 1983; 3(3-4):157-65. PubMed ID: 6610851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of interleukin-11 on high-dose methotrexate (HDMTX) induced mucositis in Wistar rats].
    Han YQ; Chen LJ; Sun XJ; Zhao GF; Cheng XY
    Zhonghua Xue Ye Xue Za Zhi; 2004 Dec; 25(12):740-4. PubMed ID: 15730719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil infiltration and oxidative stress may play a critical role in methotrexate-induced renal damage.
    Kolli VK; Abraham P; Isaac B; Selvakumar D
    Chemotherapy; 2009; 55(2):83-90. PubMed ID: 19145077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides.
    Pinedo HM; Zaharko DS; Bull JM; Chabner BA
    Cancer Res; 1976 Dec; 36(12):4418-24. PubMed ID: 1087180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose leucovorin as sole therapy for methotrexate toxicity.
    Flombaum CD; Meyers PA
    J Clin Oncol; 1999 May; 17(5):1589-94. PubMed ID: 10334548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment.
    Fan C; Cool JC; Scherer MA; Foster BK; Shandala T; Tapp H; Xian CJ
    Bone; 2009 Jan; 44(1):61-70. PubMed ID: 18976724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of high-dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function.
    Hempel L; Misselwitz J; Fleck C; Kentouche K; Leder C; Appenroth D; Rost M; Zintl F
    Med Pediatr Oncol; 2003 Jun; 40(6):348-54. PubMed ID: 12692801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.